Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
The Doctors of USC
A Phase II Randomized Study of Bortezomib/Dexamethasone With or Without Elotuzumab in Subjects with Relapsed/Refractory Multiple Myeloma.
Open to Accrual
Chemotherapy: Systemic, Immunotherapy
Defintions of terms and FAQ about clinical trials.
Ann Mohrbacher, M.D.
Other Trial Staff:
Lori Vergara, R.N., Ibrahim Syed, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.